연구 동향

American journal of ophthalmology2026-09-17

각막 내피의 재생 및 대체: 세포치료, 조직공학, 분자 및 약리학적 전략의 발전

Regeneration and Replacement of the Corneal Endothelium: Advances in Cell Therapy, Tissue Engineering, Molecular and Pharmacologic Strategies

Cancer chemotherapy and pharmacology2026-09-17

재발성 또는 난치성 B세포 급성 림프모구성 백혈병 환자에서 국소 생산 기증자 유래 항-CD19 CAR-T세포의 임상 결과

Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients

Acta oncologica (Stockholm, Sweden)2026-09-17

Association between CAR T-cell persistence and improved response to salvage radiotherapy in patients with DLBCL

Cell reports2026-09-17

Albumin uptake through FcRn promotes tumor-associated macrophage maturation and albumin-bound immunotherapy response

Oncoimmunology2026-09-17

Immune checkpoint knockout screen reveals TIGIT-CD155 interaction as a significant modulator of adapter CAR-T cell function in acute myeloid leukemia

Haematologica2026-09-17

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Haematologica2026-09-17

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era

bioRxiv (프리프린트)2026-09-17프리프린트 · 동료심사 전

Spatially distributed growth factor environments for evaluating hydrogel-based CD34+ cell culture conditions

bioRxiv (프리프린트)2026-09-17프리프린트 · 동료심사 전

C1q from C1q+ tumor-associated myeloid cells promotes resistance to T-cell engagers and CAR T-cells and is induced by LIF and glucocorticoids

bioRxiv (프리프린트)2026-09-17프리프린트 · 동료심사 전

In vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cells

bioRxiv (프리프린트)2026-09-17프리프린트 · 동료심사 전

Integrated Continuous Biomanufacturing of Recombinant Adeno-Associated Virus

Advanced science (Weinheim, Baden-Wurttemberg, Germany)2026-09-16

FOXP1 Knockdown Reprograms Th9 CAR-T Cells to Overcome Antigen Escape

Aktuelle Urologie2026-09-16

[전이성 거세저항성 전립선암(mCRPC)의 분자 진단 및 개인 맞춤 치료]

[Molecular Diagnostics and Personalized Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC)]

Metabolic brain disease2026-09-16

자폐스펙트럼장애의 hPSCs 유래 신경 모델에서 CRISPR 기반 기능유전체학

CRISPR-Enabled functional genomics in hPSCs-derived neural models for autism spectrum disorder

British journal of haematology2026-09-16

CAR-T 세포 치료 이후 환자 보고 증상 부담

Patient-reported symptom burden after chimeric antigen receptor T-cell therapy

Immunotherapy2026-09-16

원발성 중추신경계 림프종에서 CAR-T 세포 치료의 효능 및 안전성: 체계적 문헌고찰 및 메타분석

Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysis

Future oncology (London, England)2026-09-16

재발 또는 불응 서서히 자라는 비호지킨 림프종 환자를 위한 axicabtagene ciloleucel의 ZUMA-5 연구에 대한 평문 요약

Plain language summary of the ZUMA-5 study of axicabtagene ciloleucel for people with relapsed or refractory slow-growing non-Hodgkin lymphoma

bioRxiv (프리프린트)2026-09-16프리프린트 · 동료심사 전

Chemically modified CRISPR enzymes for multi-organ genome editing in vivo

bioRxiv (프리프린트)2026-09-16프리프린트 · 동료심사 전

Discovery of a Small-Molecule mTORC1 Pathway Activator that Enhances Adoptive T-Cell Therapy via Immuno-metabolic Reprogramming of CD8+ T Cells

bioRxiv (프리프린트)2026-09-16프리프린트 · 동료심사 전

Dendritic cell PD-L2 restrains intratumoral CD8+ T cell immunity

bioRxiv (프리프린트)2026-09-16프리프린트 · 동료심사 전

Oncohistone inhibition reshapes tumor-microenvironment communication in Diffuse Midline Glioma (DMG)

Annals of hematology2026-09-15

진행성 다발성 골수종에서 CELMoD 기반 브릿징 후 2차 CAR-T 세포 치료로서의 cilta-cel에 대한 조기 깊은 반응

Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma

Toxicological sciences : an official journal of the Society of Toxicology2026-09-15

자가면역질환을 위한 CAR 개선 조절 T 세포 치료제 SBT777101의 비임상 안전성 평가

Nonclinical Safety Assessment of SBT777101, a CAR-Engineered Regulatory T Cell Therapy for Autoimmune Diseases

Cancer letters2026-09-15

페롭토시스의 조절이 방사선 치료와 면역 치료를 연결하여 암 치료 결과를 개선한다

Modulation of Ferroptosis Bridges Radiotherapy and Immunotherapy to Improve Cancer Treatment Outcomes

Transplantation and cellular therapy2026-09-15

혈액 악성 종양의 CAR-T 세포 치료에서 면역 관련 유해사건의 발생률 및 치료 반응과의 상관관계

Incidence rates of immune-related adverse events and their correlation with response in hematological malignancies treated with Chimeric Antigen Receptor T-Cells

Cell reports. Medicine2026-09-15

단일세포 추적이 흑색종 TIL 치료 중 종양 반응 T 세포의 가소성을 밝혀낸다

Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy

Cancer2026-09-15

흑색종 및 고형종양에서 자가 세포 치료의 올해 주요 진전

Top advances of the year in autologous cellular therapy in melanoma and solid tumors

Proceedings of the National Academy of Sciences of the United States of America2026-09-14

인터페론의 국소 전달이 항원 제시를 회복하고 수모세포종을 T 세포 살상에 민감하게 함

Local delivery of interferon restores antigen presentation and sensitizes medulloblastoma to T cell killing

bioRxiv (프리프린트)2026-09-14프리프린트 · 동료심사 전

신약 개발을 위한 인간 유도만능줄기세포 유래 대식세포에서 CRISPR/Cas9을 이용한 유전적 교란 스크리닝의 고처리량 플랫폼

High-throughput platforms for genetic perturbation screening using CRISPR/Cas9 in human iPSC-derived macrophages for drug discovery

bioRxiv (프리프린트)2026-09-14프리프린트 · 동료심사 전

환자 유래 복수를 통한 난소암 유사 종양 미세환경 내 γδCAR T 세포의 기능적 이점 규명

Patient-derived ascites reveals functional advantages of γδCAR T-cells within the ovarian cancer-like tumor microenvironment

bioRxiv (프리프린트)2026-09-14프리프린트 · 동료심사 전

밀폐형 자동화 CAR-T 세포 제조: 연구에서 현장 생산까지

Closed, Automated CAR-T Cell Manufacturing: from Research to Point of Care production

International immunopharmacology2026-09-13

신경교종 치료를 위한 차세대 CAR-T 세포 엔지니어링: 수용체 설계, 항원 표적화 및 치료 지속성 혁신에 대한 검토

Engineering next-generation CAR-T cells for glioblastoma treatment: a review of innovations in receptor design, antigen targeting, and therapeutic persistence

Cytokine & growth factor reviews2026-09-12

Mechanism and clinical relevance of metabolic-immune cross-talk in pancreatic tumor microenvironment

Journal for immunotherapy of cancer2026-09-12

PSMA 표적화 전립선암 치료의 신경독성 위험 해결을 위한 PLP1 유발 NOT 게이트

PLP1-triggered NOT gate to address neurotoxicity risk of PSMA-targeted prostate cancer therapy

Cancer treatment and research communications2026-09-12

대형 B세포 림프종에서 CAR-T 세포 치료 후 재발 및 진행: 양상, 기전, 그리고 구제 전략

Relapse and progression after CAR-T cell therapy in large B-cell lymphoma: Patterns, mechanisms, and salvage strategies

European journal of haematology2026-09-11

원발성 형질세포백혈병 치료를 위한 조혈모세포 이식 전략: 독일 다기관 분석

Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis

Journal of structural biology2026-09-11

CD8(+) T 세포의 전하 역전 신항원 UTP20(D2661H) 인식의 구조적 기반

Structural basis for CD8(+) T cell recognition of the charge-reversed neoantigen UTP20(D2661H)

Med (New York, N.Y.)2026-09-11

전신 중증 근무력증: 주목할 임상시험

Generalized myasthenia gravis: Clinical trials to watch

Current treatment options in oncology2026-09-11

흑색종에 대한 종양 침윤 림프구 치료의 최근 진전

Recent Advances in Tumor-Infiltrating Lymphocyte Therapy for Melanoma

Human gene therapy2026-09-11

카이메라 항원 수용체 T세포의 자연살해세포 표적화: 붉은원숭이 말초혈액 및 조직

Chimeric Antigen Receptor T Cell Targeting of Natural Killer Cells in Peripheral Blood and Tissues of Rhesus Macaques